| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.48 | 0.08 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |